ACHFF (Arch Biopartners) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Arch Biopartners ROE % Adjusted to Book Value?

Arch Biopartners's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Arch Biopartners's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Arch Biopartners's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Arch Biopartners ROE % Adjusted to Book Value Historical Data

The historical data trend for Arch Biopartners's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners ROE % Adjusted to Book Value Chart

Arch Biopartners Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Arch Biopartners Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															Negative Equity	-	-	-	-

Competitive Comparison of Arch Biopartners's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Arch Biopartners's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's ROE % Adjusted to Book Value falls into.

Arch Biopartners ROE % Adjusted to Book Value Calculation

Arch Biopartners's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Arch Biopartners's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Arch Biopartners ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ARCH:Canada

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.